Race and Ethnicity Influences Collection of Granulocyte Colony-Stimulating Factor-Mobilized Peripheral Blood Progenitor Cells from Unrelated Donors, a Center for International Blood and Marrow Transplant Research Analysis

Biology of Blood and Marrow Transplantation

Volumn 21, Issue 1, 2015, Pages 165-171

  Hsu, Jack W ^a   Wingard, John R ^a   Logan, Brent R ^b   Chitphakdithai, Pintip ^c   Akpek, Gorgun ^d   Anderlini, Paolo ^e   Artz, Andrew S ^f   Bredeson, Chris ^g   Goldstein, Steven ^h   Hale, Gregory ⁱ   Hematti, Peiman ^j   Joshi, Sarita ^k   Kamble, Rammurti T ^l   Lazarus, Hillard M ^m   O'Donnell, Paul V ⁿ   Pulsipher, Michael A ^o   Savani, Bipin N ^p   Schears, Raquel M ^q   Shaw, Bronwen E ^r   Confer, Dennis L ^c,s  

^a UNIVERSITY OF FLORIDA   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c CENTER FOR INTERNATIONAL BLOOD AND MARROW TRANSPLANT RESEARCH   (United States)

^d Banner MD Anderson Cancer Center   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^f UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^g UNIVERSITY OF OTTAWA   (Canada)

^h UNIVERSITY OF MICHIGAN   (United States)

ⁱ JOHNS HOPKINS ALL CHILDREN S HOSPITAL   (United States)

^j University of Wisconsin Health   (United States)

^k NATIONWIDE CHILDREN S HOSPITAL   (United States)

^l CENTER FOR CELL AND GENE THERAPY   (United States)

^m UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

ⁿ USA   (United States)

^o UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^p VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^q MAYO CLINIC ROCHESTER   (United States)

^r ANTHONY NOLAN RESEARCH INSTITUTE   (United Kingdom)

^s NATIONAL MARROW DONOR PROGRAM   (United States)

more..

Author keywords

Ethnicity; Granulocyte colony stimulating factor (G CSF); Mobilization; Race

Indexed keywords

FILGRASTIM; CD34 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT PROTEIN;

ADULT; AFRICAN AMERICAN; ARTICLE; ASIAN; BODY MASS; CAUCASIAN; CD34 SELECTION; CONTROLLED STUDY; DRUG DOSE REDUCTION; ETHNIC GROUP; FEMALE; GRAFT REJECTION; HISPANIC; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MONONUCLEAR CELL; OBESITY; ORGAN DONOR; PACIFIC ISLANDER; PATIENT SAFETY; PERIPHERAL BLOOD STEM CELL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; SELF REPORT; STEM CELL MOBILIZATION; UNDERWEIGHT; UNRELATED DONORS; YOUNG ADULT; ADOLESCENT; ANCESTRY GROUP; CELL COUNT; CYTOLOGY; IMMUNOLOGY; INTERNATIONAL COOPERATION; META ANALYSIS; PROCEDURES; SUBCUTANEOUS DRUG ADMINISTRATION;

ADOLESCENT; ADULT; ANTIGENS, CD34; BODY MASS INDEX; CELL COUNT; CONTINENTAL POPULATION GROUPS; FEMALE; FILGRASTIM; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; INJECTIONS, SUBCUTANEOUS; INTERNATIONAL COOPERATION; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RECOMBINANT PROTEINS; UNRELATED DONORS;

EID: 84927166294     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2014.10.007     Document Type: Article

References (33)

1. Bensinger W.I., Martin P.J., Storer B., et al. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. NEngl J Med 2001, 344:175-181.
2. Pasquini MC, Wang Z. Current use and outcome of hematopoietic stem cell transplantation: CIBMTR Summary Slides, 2013. Available at: http://www.cibmtr.org.
3. Takeyama K., Ohto H. PBSC mobilization. Transfus Apher Sci 2004, 31:233-243.
4. Ings S.J., Balsa C., Leverett D., et al. Peripheral blood stem cell yield in 400 normal donors mobilised with granulocyte colony-stimulating factor (G-CSF): impact of age, sex, donor weight and type of G-CSF used. Br J Haematol 2006, 134:517-525.
5. Anderlini P., Przepiorka D., Seong C., et al. Factors affecting mobilization of CD34+ cells in normal donors treated with filgrastim. Transfusion (Paris) 1997, 37:507-512.
6. Grigg A.P., Roberts A.W., Raunow H., et al. Optimizing dose and scheduling of filgrastim (granulocyte colony-stimulating factor) for mobilization and collection of peripheral blood progenitor cells in normal volunteers. Blood 1995, 86:4437-4445.
7. Miflin G., Charley C., Stainer C., et al. Stem cell mobilization in normal donors for allogeneic transplantation: analysis of safety and factors affecting efficacy. Br J Haematol 1996, 95:345-348.
8. Hsieh M.M., Tisdale J.F., Rodgers G.P., et al. Neutrophil count in African Americans: lowering the target cutoff to initiate or resume chemotherapy?. JClin Oncol 2010, 28:1633-1637.
9. Vasu S., Leitman S.F., Tisdale J.F., et al. Donor demographic and laboratory predictors of allogeneic peripheral blood stem cell mobilization in an ethnically diverse population. Blood 2008, 112:2092-2100.
10. Carilli A.R., Sugrue M.W., Rosenau E.H., et al. African American adult apheresis donors respond to granulocyte-colony-stimulating factor with neutrophil and progenitor cell yields comparable to those of Caucasian and Hispanic donors. Transfusion (Paris) 2012, 52:166-172.
11. Richa E., Papari M., Allen J., et al. Older age but not donor health impairs allogeneic granulocyte colony-stimulating factor (G-CSF) peripheral blood stem cell mobilization. Biol Blood Marrow Transplant 2009, 15:1394-1399.
12. Horowitz M. The role of registries in facilitating clinical research in BMT: examples from the Center for International Blood and Marrow Transplant Research. Bone Marrow Transplant 2008, 42(Suppl 1):S1-S2.
13. Gordon M.Y., Bearpark A.D., Clarke D., Dowding C.R. Haemopoietic stem cell subpopulations in mouse and man: discrimination by differential adherence and marrow repopulating ability. Bone Marrow Transplant 1990, 5(Suppl 1):6-8.
14. Greenbaum A.M., Link D.C. Mechanisms of G-CSF-mediated hematopoietic stem and progenitor mobilization. Leukemia 2011, 25:211-217.
15. Lévesque J.P., Takamatsu Y., Nilsson S.K., et al. Vascular cell adhesion molecule-1 (CD106) is cleaved by neutrophil proteases in the bone marrow following hematopoietic progenitor cell mobilization by granulocyte colony-stimulating factor. Blood 2001, 98:1289-1297.
16. Lévesque J.-P., Hendy J., Winkler I.G., et al. Granulocyte colony-stimulating factor induces the release in the bone marrow of proteases that cleave c-KIT receptor (CD117) from the surface of hematopoietic progenitor cells. Exp Hematol 2003, 31:109-117.
17. Ratajczak M.Z., Lee H., Wysoczynski M., et al. Novel insight into stem cell mobilization-plasma sphingosine-1-phosphate is a major chemoattractant that directs the egress of hematopoietic stem progenitor cells from the bone marrow and its level in peripheral blood increases during mobilization due to activation of complement cascade/membrane attack complex. Leukemia 2010, 24:976-985.
18. Roberts A.W., Foote S., Alexander W.S., et al. Genetic influences determining progenitor cell mobilization and leukocytosis induced by granulocyte colony-stimulating factor. Blood 1997, 89:2736-2744.
19. Geiger H., Szilvassy S.J., Ragland P., Van Zant G. Genetic analysis of progenitor cell mobilization by granulocyte colony-stimulating factor: verification and mechanisms for loci on murine chromosomes 2 and 11. Exp Hematol 2004, 32:60-67.
20. Bogunia-Kubik K., Gieryng A., Gebura K., Lange A. Genetic variant of the G-CSF receptor gene is associated with lower mobilization potential and slower recovery of granulocytes after transplantation of autologous peripheral blood progenitor cells. Cytokine 2012, 60:463-467.
21. Bogunia-Kubik K., Gieryng A., Dlubek D., Lange A. The CXCL12-3'A allele is associated with a higher mobilization yield of CD34 progenitors to the peripheral blood of healthy donors for allogeneic transplantation. Bone Marrow Transplant 2009, 44:273-278.
22. Martín-Antonio B., Carmona M., Falantes J., et al. Impact of constitutional polymorphisms in VCAM1 and CD44 on CD34+ cell collection yield after administration of granulocyte colony-stimulating factor to healthy donors. Haematologica 2011, 96:102-109.
23. Lenk J., Bornhauser M., Kramer M., et al. Sex and body mass index but not CXCL12 801 G/A polymorphism determine the efficacy of hematopoietic cell mobilization: a study in healthy volunteer donors. Biol Blood Marrow Transplant 2013, 19:1517-1521.
24. Köhler A., Schmithorst V., Filippi M.-D., et al. Altered cellular dynamics and endosteal location of aged early hematopoietic progenitor cells revealed by time-lapse intravital imaging in long bones. Blood 2009, 114:290-298.
25. Adams G.B., Martin R.P., Alley I.R., et al. Therapeutic targeting of a stem cell niche. Nat Biotechnol 2007, 25:238-243.
26. Bell N.H., Greene A., Epstein S., et al. Evidence for alteration of the vitamin D-endocrine system in blacks. JClin Invest 1985, 76:470-473.
27. Bell N.H., Epstein S., Greene A., et al. Evidence for alteration of the vitamin D-endocrine system in obese subjects. JClin Invest 1985, 76:370-373.
28. Katayama Y., Battista M., Kao W.-M., et al. Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell 2006, 124:407-421.
29. Méndez-Ferrer S., Lucas D., Battista M., Frenette P.S. Haematopoietic stem cell release is regulated by circadian oscillations. Nature 2008, 452:442-447.
30. Lucas D., Battista M., Shi P.A., et al. Mobilized hematopoietic stem cell yield depends on species-specific circadian timing. Cell Stem Cell 2008, 3:364-366.
31. Gomes A.L., Carvalho T., Serpa J., et al. Hypercholesterolemia promotes bone marrow cell mobilization by perturbing the SDF-1:CXCR4 axis. Blood 2010, 115:3886-3894.
32. Crysandt M., Hilgers R.-D., von Hobe S., et al. Hypercholesterolemia and its association with enhanced stem cell mobilization and harvest after high-dose cyclophosphamide+G-CSF. Bone Marrow Transplant 2011, 46:1426-1429.
33. Meadows T.A., Bhatt D.L., Hirsch A.T., et al. Ethnic differences in the prevalence and treatment of cardiovascular risk factors in US outpatients with peripheral arterial disease: insights from the reduction of atherothrombosis for continued health (REACH) registry. Am Heart J 2009, 158:1038-1045.